The altered behavioral phenotype was associated with dysregulation of genes and metabolites known to be involved in motor control and anxiety-like behavior pathways, like adrenaline, dopamine, 5-hydroxytryptophan (5-HT), postsynaptic density protein 95 (PSD-95), and synaptophysin (80). This evidence concerns the gene DLG4 and Anxiety.